Cargando…
Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation
The development of efficacious means of delivering antioxidant polyphenols from natural sources for the treatment of skin diseases is of great interest for many cosmetic and pharmaceutical companies. Resveratrol (RSV) and Limonene (LIM) have been shown to possess good anti-inflammatory and antibacte...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254386/ https://www.ncbi.nlm.nih.gov/pubmed/32365956 http://dx.doi.org/10.3390/ma13092073 |
_version_ | 1783539533247152128 |
---|---|
author | Angellotti, Giuseppe Murgia, Denise Presentato, Alessandro D’Oca, Maria Cristina Scarpaci, Amalia Giulia Alduina, Rosa Raimondi, Maria Valeria De Caro, Viviana |
author_facet | Angellotti, Giuseppe Murgia, Denise Presentato, Alessandro D’Oca, Maria Cristina Scarpaci, Amalia Giulia Alduina, Rosa Raimondi, Maria Valeria De Caro, Viviana |
author_sort | Angellotti, Giuseppe |
collection | PubMed |
description | The development of efficacious means of delivering antioxidant polyphenols from natural sources for the treatment of skin diseases is of great interest for many cosmetic and pharmaceutical companies. Resveratrol (RSV) and Limonene (LIM) have been shown to possess good anti-inflammatory and antibacterial properties against Staphylococcus aureus infections responsible for many skin disorders, such as acne vulgaris. In this study, solid lipid microparticles are designed as composite vehicles capable of encapsulating a high amount of trans-RSV and enhancing its absorption through the stratum corneum. A microparticulate system based on mixture of PEGylate lipids, long-chain alcohols and LIM is able to entrap RSV in an amorphous state, increasing its half-life and avoiding inactivation due to isomerization phenomena, which represents the main drawback in topical formulations. Particles have been characterized in term of shape, size distribution and drug loading. Antimicrobial tests against S. aureus have highlighted that empty microspheres possess per se antimicrobial activity, which is enhanced by the presence of LIM, demonstrating that they can represent an interesting bactericide vehicle for RSV administration on the skin. |
format | Online Article Text |
id | pubmed-7254386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72543862020-06-10 Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation Angellotti, Giuseppe Murgia, Denise Presentato, Alessandro D’Oca, Maria Cristina Scarpaci, Amalia Giulia Alduina, Rosa Raimondi, Maria Valeria De Caro, Viviana Materials (Basel) Article The development of efficacious means of delivering antioxidant polyphenols from natural sources for the treatment of skin diseases is of great interest for many cosmetic and pharmaceutical companies. Resveratrol (RSV) and Limonene (LIM) have been shown to possess good anti-inflammatory and antibacterial properties against Staphylococcus aureus infections responsible for many skin disorders, such as acne vulgaris. In this study, solid lipid microparticles are designed as composite vehicles capable of encapsulating a high amount of trans-RSV and enhancing its absorption through the stratum corneum. A microparticulate system based on mixture of PEGylate lipids, long-chain alcohols and LIM is able to entrap RSV in an amorphous state, increasing its half-life and avoiding inactivation due to isomerization phenomena, which represents the main drawback in topical formulations. Particles have been characterized in term of shape, size distribution and drug loading. Antimicrobial tests against S. aureus have highlighted that empty microspheres possess per se antimicrobial activity, which is enhanced by the presence of LIM, demonstrating that they can represent an interesting bactericide vehicle for RSV administration on the skin. MDPI 2020-04-30 /pmc/articles/PMC7254386/ /pubmed/32365956 http://dx.doi.org/10.3390/ma13092073 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Angellotti, Giuseppe Murgia, Denise Presentato, Alessandro D’Oca, Maria Cristina Scarpaci, Amalia Giulia Alduina, Rosa Raimondi, Maria Valeria De Caro, Viviana Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation |
title | Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation |
title_full | Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation |
title_fullStr | Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation |
title_full_unstemmed | Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation |
title_short | Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation |
title_sort | antibacterial pegylated solid lipid microparticles for cosmeceutical purpose: formulation, characterization, and efficacy evaluation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254386/ https://www.ncbi.nlm.nih.gov/pubmed/32365956 http://dx.doi.org/10.3390/ma13092073 |
work_keys_str_mv | AT angellottigiuseppe antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation AT murgiadenise antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation AT presentatoalessandro antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation AT docamariacristina antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation AT scarpaciamaliagiulia antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation AT alduinarosa antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation AT raimondimariavaleria antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation AT decaroviviana antibacterialpegylatedsolidlipidmicroparticlesforcosmeceuticalpurposeformulationcharacterizationandefficacyevaluation |